Brief Psychiatric Rating Scale (BPRS)

Abstract

The Brief Psychiatric Rating Scale (BPRS), developed by Overall and Gorham in 1962, is a foundational assessment instrument in clinical psychology and psychiatry. It was designed as a concise tool—originally 16 items, later standardized to 18 items—intended for the rapid evaluation of core psychiatric symptoms and, crucially, the monitoring of treatment efficacy, particularly concerning pharmacologic treatments. The BPRS was derived from earlier, more extensive instruments, such as the Lorr Multidimensional Scale for Rating Psychiatric Patients (MSRPP) and the Lorr Inpatient Multidimensional Psychiatric Scale (IMPS), maintaining comprehensive coverage while maximizing efficiency. The administration supports structured interviews, requiring trained raters only 2–3 minutes to complete the evaluation following a structured interaction period, which includes time allocated for establishing rapport, non-directive interaction, and direct questioning.

Keywords

Brief Psychiatric Rating Scale, Psychological Assessment, Pharmacologic Treatment Outcomes, Test Development, Drug Therapy, Treatment Outcomes, Rating Scales, Psychiatric Symptoms

Authors

Overall, J. E., Gorham, D. R.

Purpose

The primary purpose of the BPRS is twofold: first, to provide a systematic and standardized measure for assessing the severity and range of psychiatric symptoms present in a patient population. It offers a standardized method for quantifying the extent of psychopathology.

Second, and perhaps most critically for its original clinical application, the scale is used to evaluate the effectiveness and monitor changes resulting from drug therapy interventions in psychiatric patients. This makes the BPRS highly valuable in clinical trials and longitudinal studies focused on treatment response.

Construct

The BPRS primarily measures the overarching construct of Psychiatric Symptom Changes. It focuses on observable signs and reported symptoms related to fundamental dimensions of psychopathology, including mood disturbances, thought disorders, and behavioral manifestations.

The scale’s structure is specifically tailored to detect fluctuations in symptom severity over time, thereby functioning effectively as an outcome measure within clinical trials designed to test novel or existing pharmacologic treatments.

Validity

The initial documentation provided for the BPRS does not explicitly indicate specific studies or coefficients demonstrating formal construct or criterion validity. Consequently, the original source table states: “No validity indicated.”

However, the BPRS has achieved status as a gold standard in psychiatric clinical research due to its strong face validity and decades of subsequent empirical validation supporting its utility in assessing acute symptom presentation across various severe mental illnesses.

Reliability

Reliability estimates for the BPRS focused primarily on inter-rater reliability, which is crucial given that the scale relies on the subjective judgment and interpretation of a trained clinician during an interview setting.

Initial studies, based on ratings derived from 83 newly admitted schizophrenic patients, showed inter-rater correlations ranging from a low of .56 (for the item assessing “Tension”) to a high of .87. These results indicate acceptable to good consistency among different clinicians using the scale, supporting its use in multi-site research where standardization of ratings is essential.

Factor Analysis

The original test documentation provided does not include results from a formal factor analysis (“No factor analysis indicated”).

Subsequent extensive research has been performed on the BPRS structure, typically identifying four to five key factors, such as Hostility/Suspiciousness, Anxiety/Depression, Thought Disturbance, and Withdrawal/Retardation. These factors allow researchers to group symptoms for more targeted analysis of treatment effects.

Instrument

Test Type: Rating Scale, Observer-rated

Format: Items are rated by a trained clinician on a 7-point severity scale, ranging from 1 (“not present”) to 7 (“extremely severe”).

Language Available: English (The BPRS has been widely translated and validated for use in numerous languages globally.)

Population Group: Human

Age Group: Adults

Population Details: Primarily used with psychiatric patients, including those diagnosed with psychotic disorders, and those involved in clinical trials for severe mental disorders like schizophrenia.

Test Methodology: Structured clinical interview followed by subjective rating by a trained mental health professional. The administration is highly standardized, involving specific timings for rapport building (3 minutes), non-directive interaction (10 minutes), and direct questioning (5 minutes).

Keywords

Brief Psychiatric Rating Scale, Clinical Trials, Symptom Assessment, Drug Efficacy, Inter-rater reliability, Schizophrenia, Test Construction

Authors

Author ORCID Identifier: N/A (Historical Instrument)

Affiliation Email addresses: N/A

Correspondence Address: N/A

Permissions & Fee and Test Year

The Brief Psychiatric Rating Scale was first developed and published in 1962. While the core items are widely referenced in academic literature, formal administration manuals and specific training materials may require licensing or permission, particularly when used in large-scale governmental or industry-sponsored clinical trials.

Test Year: 1962

Reference’s

1. Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10(3), 799–812.

2. Guy, William (1976). ECDEU Assessment Manual. 612 pp. US Department of Health, Education and Welfare (HEW). https://doi.org/10.1037/e591322011-001

Items of the Brief Psychiatric Rating Scale (BPRS)

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The source content indicates that the specific test items are not available for inclusion in this public domain entry (“Test Items Available: No”). However, the BPRS is commonly recognized as consisting of 18 items that assess psychiatric phenomena, including but not limited to: Somatic Concern, Anxiety, Emotional Withdrawal, Conceptual Disorganization, Guilt Feelings, Tension, Mannerisms and Posturing, Grandiosity, Depressive Mood, Hostility, Suspiciousness, Hallucinatory Behavior, Motor Retardation, Uncooperativeness, Unusual Thought Content, Blunted Affect, Excitement, and Disorientation.